AIM ImmunoTech Inc. - 10-Q Filing

AIM ImmunoTech Inc. reports Q3 2026 financial results including detailed equity structures and ongoing clinical research expenditures.

SEC EDGAR ·

Tickers: $AIM

Read the full article at SEC EDGAR

More Regulatory news